Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 78667J108
Event date: 2024-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 39,757
- Percent of class
- 0.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-24-000310
- Form type
- SC 13G
- Filer
- Sage Therapeutics, Inc.
- CIK
- CIK 1597553
- Filed
- Jun 06, 2024
- Reporting period
- May 31, 2024
- Description
- Schedule 13G beneficial ownership